Outlook Therapeutics (OTLK) announced Faisal Sukhtian has been appointed as Chairman of the Board of Directors, effective immediately. Sukhtian will assume the role from Randy Thurman, who will remain on the Board as Lead Independent Director.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OTLK:
- Outlook Therapeutics announces presentation of data from NORSE EIGHT
- Outlook Therapeutics enters into agreement for warrant inducement transaction
- Outlook Therapeutics’ ONS-5010 shown to be non-inferior to Lucentis in wet AMD
- Biotech Alert: Searches spiking for these stocks today
- Outlook Therapeutics Faces Business Risks from Third-Party Manufacturing Dependencies
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue